|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.24 EUR | +2.23% |
|
-1.90% | +8.61% |
| 01:55am | PHILIPS NV : UBS gives a Buy rating | ZD |
| 01-20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
| 18.66B | -3.9% | 11.53% | 10.82% | -2.4% | 1.76x | ||
| 42.88B | 14.77% | 22.64% | 17.4% | 8.55% | 2.51x | ||
| 8.35B | 27.81% | 36.72% | 17.75% | 13.59% | -0.58x | ||
| 23.88B | 16.33% | 28.89% | 7.57% | 4.81% | 1.93x | ||
| 16.75B | 11.06% | 27.04% | 18.15% | 10% | 2.14x | ||
| 27.43B | 9.17% | 16.49% | 14.77% | 5.92% | 2.84x | ||
| 5.44B | 76.75% | 27.84% | 17.48% | 12.98% | -2.02x | ||
| 6.95B | 18.75% | 25.66% | 25.19% | 12.96% | 0.8x | ||
| 5.15B | 27.22% | 34.26% | 25.97% | 18.7% | -0.29x | ||
| 19.67B | 10.13% | 16.32% | 25.59% | 6.29% | 1.6x | ||
| 5.03B | 31.77% | 35.7% | 32.58% | 22.31% | -1.13x | ||
| 2.96B | 21.56% | 30.97% | 42.82% | 13.9% | 1.17x | ||
| 4.37B | -27.97% | 13.27% | 9.61% | 4.75% | 0.95x | ||
| 4.1B | 13.8% | 30.18% | 19.07% | 10.68% | 0.23x | ||
| 6.66B | 11.82% | 16.29% | 15.6% | 10.72% | -0.1x | ||
| 2.76B | 9.81% | 28.28% | 7.75% | 4.64% | 2.34x | ||
| 3.37B | 3.36% | 15.39% | 22.59% | 7.17% | 3.17x | ||
| 36.5M | -569.23% | -256.8% | - | -36.28% | 2.13x | ||
| Average | 11.36B | -16.5% | 8.93% | 19.45% | 7.18% | 1.08x | |
| Weighted average by Cap. | 19.9B | 14.98% | 25.05% | 17.35% | 9.37% | 1.24x |
- Stock Market
- Equities
- PHIA Stock
- Sector Philips NV
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















